Related Experiment Video
Updated: Aug 22, 2026

Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine
Published on: September 19, 2025
Making zombies to kill cancer
1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72212, USA.
Abstract:
Genotoxic drugs induce apoptosis-resistant senescent "zombie" cells. In this issue of Cell Chemical Biology, Gallagher Aldave et al.1 show that these cells acquire dependence on BCL-xL and MCL-1, creating a therapeutic vulnerability to their inhibitors and degraders.
Insights
Genotoxic drugs create apoptosis-resistant senescent cells. These "zombie" cells become dependent on BCL-xL and MCL-1, offering a new therapeutic target for cancer treatment.
Area of Science:
- Cellular senescence
- Cancer biology
- Drug discovery
Background:
- Genotoxic drugs can induce cellular senescence, a state of irreversible growth arrest.
- Senescent cells, often termed "zombie" cells, resist apoptosis (programmed cell death).
Purpose of the Study:
- To investigate the molecular mechanisms underlying apoptosis resistance in senescent cells induced by genotoxic drugs.
- To identify potential therapeutic vulnerabilities in these senescent cells.
Main Methods:
- Utilized cell culture models treated with genotoxic drugs.
- Performed molecular analyses to assess protein expression and cellular dependencies.
- Tested the efficacy of BCL-xL and MCL-1 inhibitors and degraders.
Main Results:
- Genotoxic drugs induce senescent cells that exhibit resistance to apoptosis.
- These senescent cells demonstrate a critical dependence on the anti-apoptotic proteins BCL-xL and MCL-1.
- Inhibition or degradation of BCL-xL and MCL-1 effectively eliminates these senescent cells.
Conclusions:
- Senescent cells induced by genotoxic drugs represent a unique therapeutic target.
- Targeting BCL-xL and MCL-1 exploits a specific vulnerability in these resistant cells.
- This finding opens new avenues for cancer therapy by eliminating therapy-induced senescent cells.
Related Concept Videos
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

